Palorini, F.
79  Ergebnisse:
Personensuche X
?
 
?
3

EP-1923 Dimensionality reduction of radiomic features using..:

Tenconi, C. ; Rancati, T. ; Palorini, F....
Radiotherapy and Oncology.  133 (2019)  - p. S1046-S1047 , 2019
 
?
4

OC-0616 Introducing information on gut microbiota into toxi..:

Rancati, T. ; Bedini, N. ; De Cecco, L....
Radiotherapy and Oncology.  133 (2019)  - p. S326-S327 , 2019
 
?
 
?
7

Evaluation of Inflammatory Marker Levels in Patients Treate..:

Palorini, F. ; Bedini, N. ; Avuzzi, B....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e132-e133 , 2018
 
?
9

Clinical Results for an Active Surveillance Cohort with Loc..:

Torrente, S. ; Andreani, S. ; Badenchini, F....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e145-e146 , 2018
 
?
10

PV-0320: NTCP models of late severe urinary symptoms after ..:

Palorini, F. ; Cicchetti, A. ; Rancati, T....
Radiotherapy and Oncology.  127 (2018)  - p. S169-S170 , 2018
 
?
11

SP-0459: Issues in pixel/voxel wise dose maps comparison: s..:

Palorini, F.
Radiotherapy and Oncology.  127 (2018)  - p. S237 , 2018
 
?
 
?
13

PO-0848: Predictors of patient-reported incontinence after ..:

Cozzarini, C. ; Bedini, N. ; Garibaldi, E....
Radiotherapy and Oncology.  123 (2017)  - p. S459-S460 , 2017
 
?
14

Dose-Response Curve for Textural Features of Obturator Musc..:

Scalco, E. ; Pirovano, I. ; Rancati, T....
International Journal of Radiation Oncology*Biology*Physics.  99 (2017)  2 - p. E719 , 2017
 
?
15

Compliance of prostate cancer patients on active surveillan..:

Badenchini, F. ; Palorini, F. ; Alvisi, M.F....
European Urology Supplements.  16 (2017)  3 - p. e1390-e1392 , 2017
 
1-15